Skip to main content
. 2020 Aug;9(4):1569–1584. doi: 10.21037/tlcr-20-341

Table 2. Ferroptosis inducers.

Reagents Mechanisms Formula In-vitro In-vivo Refs
Erastin System Xc C30H31ClN4O4 BJeLR, HT1080, Calu-1, A-673, Hela, 143B p0 and p+ cell NA (25,26)
Imidazole ketone erastin System Xc C35H35ClN6O5 SUDHL-2/5/6/, SUDHL-7/8/9/, SUDHL-10/16, LY-7/9/18,HT-1080, DOHH-2, HBL-1, U2932, A4/FUK, WSU-NHL, Karpas422, A3/KAW, RIVA,U937 SUDHL-6 (27)
Piperazine erastin System Xc C35H41ClN6O4 HT-1080, BJeLR, DRD59 NA (25,28)
RSL3 GPX4 C23H21ClN2O5 BJeLR, HT1080, A549, Calu-1, HCT116, MIA PaCa-2, KBM7 NA (17,29)
DPI7 GPX4 C23H22Cl2N2O3S KBM7 NA (29)
FIN56 GPX4 C25H31N3O5S2 BJeLR, HT-1080 NA (23,30)
FINO2 GPX4       – HT-1080 NA (30)
Statins GPX4       – HCC4006, HT-1080 LOXIMVI (13)
Buthionine sulfoximine GSH depletion C8H18N2O3S BJeLR, HCT116/A549 NA (28,31)
Acetaminophen GSH depletion C8H9NO2 HepG2/primary mouse hepatocytes NA (32)
Sulfasalazine System Xc inhibitor C18H14N4O5S BJeLR, HT1080, Calu-1, DU-145 HT-1080, F98 (25,31)
Sorafenib system Xc inhibition C21H16ClF3N4O3 HT1080, Calu-1, DU-145, Huh7, ACHN cells Huh7, Nude mice (31,33-36)
Artesunate GSH depletion C19H28O8 PDAC cell lines NA (35)
Lanperisone System Xc C15H18F3NO K-rasG12D-transformed MEFs Nude mice (37)
Piperazine erastin system Xc C35H41ClN6O4 BJeLR Nude mice (28)
1 S,3 R-RSL3 GPX4 C23H21ClN2O5 HT-1080, 143B; B16; COHBR1; BT474, PC9 BJeLR, HT-1080 (14,25,28,38)
Cisplatin GSH, partially inhibited by DFO, Fer-1, Z-VAD-FMK Cl2H6N2Pt A549, HCT116 NA (39)
Ferrous ammonium sulfate Iron loading H8FeN2O8S2 IMR-32 NA (40)
Ferric ammonium citrate Iron loading C12H22FeN3O14 HT-1080 NA (41)
Haemin Iron loading C34H32ClFeN4O4 IMR-32, THP-1, THP-1 NA (41,42)
Siramesine+ lapatinib Increase the iron level by upregulating TF and down regulating of FPN-1 C30H31FN2O, C29H26ClFN4O4S MDA MB231, MCF-7, ZR-75, SKBr3 NA (43)
BAY 11-7085 Increase in LIP by HMOX1 upregulation C13H15NO2S MCF-7, MDAMB-468, MDA-MB-231, A549, SKBR3, SKOV3 NA (44)
Bromelain Upregulation of ACSL-4 in Kras mutant CRC cells       – CT-116, DLD-1 NA (45)